Market: NASD |
Currency: USD
Address: 3222 Phoenixville Pike
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Show more
📈 Neuronetics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$6.50
-
Upside/Downside from Analyst Target:
103.13%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
50-100%
-
Upcoming Earnings Date:
2025-11-11
-
EPS Estimate:
-0.12
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Neuronetics, Inc.
| Date | Reported EPS |
|---|
| 2025-11-11 (estimated upcoming) | - |
| 2025-08-05 | -0.15 |
| 2025-05-06 | -0.21 |
| 2025-03-04 | -0.04 |
| 2024-11-12 | -0.44 |
| 2024-08-12 | -0.33 |
| 2024-05-07 | -0.27 |
| 2024-03-05 | -0.19 |
| 2023-11-07 | -0.33 |
| 2023-08-08 | -0.17 |
| 2023-05-09 | -0.38 |
| 2023-03-07 | -0.3 |
| 2022-11-08 | -0.28 |
| 2022-08-02 | -0.39 |
| 2022-05-12 | -0.41 |
| 2022-03-08 | -0.29 |
| 2021-11-09 | -0.31 |
| 2021-08-03 | -0.29 |
| 2021-05-04 | -0.31 |
| 2021-03-02 | -0.19 |
| 2020-11-02 | -0.18 |
| 2020-08-04 | -0.41 |
| 2020-05-05 | -0.63 |
| 2020-03-03 | -0.41 |
| 2019-11-05 | -0.37 |
📰 Related News & Research
No related articles found for "neuronetics inc".
